| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |